Want the largest market share?

Given that the cannabis market is new to consumers and policymakers in a regulatory sense, proper marketing will be crucial in building the next Marlboro or Coors as the industry evolves. Cannabis businesses and brands have to create a bonding relationship with novice consumers. But how do you land the largest market share? Is it through campaigns that create trust, education and purpose in the brand? Yes, to all of this.

After retreating almost 27% in Q3, the Canadian Cannabis LP Index extended its losing streak to five months as it fell again in November, declining 5.5.% to 225.26:

The index, which fell 30.1% in 2020 to end at 275.16, is down 22% over the past year and down 18.1% year-to-date in 2021:

It remains substantially below the all-time closing high of 1314.33 in September 2018, just ahead of Canadian adult-use legalization. In March 2020, it posted a new 52-week closing low of 196.10, a level not seen since late 2016, and it closed 14.9% above that level at the end of November:

It has been more than three years since Canada legalized recreational marijuana on Oct. 17, 2018. The road has been a bumpy one for the industry as supply issues and rising competition have made it challenging for cannabis companies in the country to grow their sales or post a profit.

The industry leader three years ago was cannabis producer Canopy Growth (NASDAQ: CGC), but it's clear it isn't in that place right now as rival Tilray generates more in revenue. A lot has changed since legalization took place, and if you were to bet that legalization would have been the opportune time to invest in Canopy Growth, you would be sorely disappointed.

Beena Goldenberg is approaching 90 days as the CEO of Organigram (NASDAQ: OGI) (TSX: OGI). While some other Canadian LPs are shutting down facilities, Organigram is in the process of expanding to keep up with customer demand. Goldenberg spoke with New Cannabis Ventures about the company’s current momentum, the British American Tobacco (BAT) investment and the company’s cash position. The audio of the entire conversation is available at the end of this written summary.

They've both been struggling for a while, and they're still deep in the woods.

When it comes to cannabis stocks, there's always a few turnaround plays that might be tempting targets for investment. As the marijuana industry grows globally, more than a couple of companies have overextended themselves by building so much output capacity that they outpaced demand. While it's a bit of a gamble, these competitors just might be a bargain, especially if they can effectively scale back their operations. 

Medicine Hat is a leading candidate for a new 200,000 square-foot processing plant that would employ 80 workers to turn hemp fibre into base material for car fenders, plywood, consumer plastics and construction material.

Inca Renewables describes the product as a bio-composite, a mixture of resin and plant fibre formed into pellets, then heated and formed into high-strength, low-weight construction and manufacturing material.

It produces four product lines, and is seeking a Western Canadian base of operations to receive hemp byproduct, process it and then distribute to industrial customers.

Greenway Greenhouse released its first-quarter financial statements since hitting markets in September.

Revenue came in at C$1.15 million ($906,547), with gross profit before fair value adjustments at C$532,263.  

For Al Harrington, who played his last NBA game in Toronto in 2014, the partnership offers another reason to return north, though this time with a different purpose.

Aras Azadian, the CEO of Avicanna, a multinational cannabis and biopharmaceutical company, is waiting in line at the passport office when he takes a call from The GrowthOp.

Having recently returned from Mexico, where his passport was stolen, he’s got a day to resolve the situation before heading off again to Brazil.

Canada House Wellness Group (CSE: CHV) ("Canada House" or the "Company"), a fully integrated medical cannabis company, is pleased to announce the achievement of several company milestones as it works towards the completion of the previously announced reverse takeover (RTO) of the Company by Montréal Cannabis Médical Inc. ("MTL Cannabis") (the "Transaction").  The Transaction is now expected to close in calendar Q1 2022, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals and the shareholder approval described below.

LoFi CBD Oil 1500 now available through the OCS

Green Light Solutions ("GLS" or "the Company"), an innovation firm committed to driving excellence in the Cannabis industry, is pleased to announce the launch of its CBD dominant brand, LoFi, in the Ontario market. The signature product, LoFi CBD Oil 1500, is now available through Ontario Cannabis Store (“OCS”), ocs.ca, and licensed retailers.

LoFi CBD Oil 1500 is a potent, full-spectrum formula with hemp-derived CBD extract and sustainably sourced MCT oil. LoFi CBD Oil 1500 ranks among the top CBD oils sold in B.C. after its launch in August this year.